Obstructive sleep apnea (OSA) is a common sleep-related breathing disorder causing cognitive dysfunction. Unfortunately, both the disease itself and this disastrous complication go unnoticed due to poor perception for the same. This review attempts to explain the pathophysiology, consequences, and treatment options for the same. The keypoint is early diagnosis and treatment of OSA so as to prevent the cognitive decline.
: Vicious cycle of neurocognitive dysfunction in obstructive sleep apnea which can be broken by early diagnosis and appropriate positive airway pressure therapy Neurocognitive impairment, ultimately, has an unfavorable effect on patients' productivity at work and social safety and quality of life. 16 Attention It is the most common impaired cognition in OSA. It has been categorized as divided, selective, and sustained attention. 17 Several studies have demonstrated that drivers with OSA have decreased visual vigilance/sustained attention, which is closely associated with sleep fragmentation/disorder-related daytime sleepiness and tiredness, and they have an increased risk of road traffic accidents. 18 Studies have also shown that OSA patients have difficulty in involuntary attention switching. 19 Damage due to loss of attention has a positive association with the OSA severity. 20
Memory
OSA is associated with both short-term and working memory deficits, which has been pathophysiologically linked to the hypoxic changes in the hippocampus. 21 One study suggests that only verbal memory was impaired in OSA patients. 22 However, there is evidence of visual memory loss also. 23 A meta-analysis concluded that immediate and delayed recalls, both, were affected in terms of visuospatial and verbal episodic memory. 24
Executive Functions
Executive function is as vulnerable to damage as other cognitive functions. This includes loss of fluid reasoning, shifting, and inhibition. A meta-analysis demonstrated that the entire function of planning, working memory, phonological fluency, and cognitive flexibility have been impaired in OSA patients. 25 
pAthophysIology b e h I n d cognItIve dysfunctIon

Excessive Sleepiness
Excessive sleepiness can account for a majority of the neurocognitive deficits in OSA, and its role may even be more than that of hypoxias. 26 , 27 Attention deficits may be a result of sleep fragmentation, again, leading to excessive daytime sleepiness. 28 , 29 
Desaturation
The old literature documents hypoxia as the principal underlying pathophysiology of cognitive dysfunction. 30 Hypoxemia may be the trigger for neuronal injury in OSA patients. 31 In fact, studies have shown that neurocognitive performance correlates with the severity of hypoxemia. 32 , 33 Dysfunction of the prefrontal cortex can adversely affect executive functioning. 34
Sleep Fragmentation
Sleep fragmentation and daytime sleepiness in OSA influence all the aspects: attention and memory and executive dysfunction. 27 , 34 , 35 An international epidemiological A survey of over 10,000 patients also concluded the same. 36 
Metabolic Factors
Metabolic disturbance of lipid and protein can contribute to cognitive impairment. 16 Pediatric OSA with cognitive dysfunction have been found to have a lower concentration of serum insulinlike growth factor (IGF). 37 Besides, the increased rate of APOE ε4 allele indicates a hereditary link for neurocognitive impairment in OSA. 38 
evIdence f r o m ImAgIng
Advancements in neuroimaging have helped to understand the structural changes in brain structure in cognitive dysfunction. This has recently been also evaluated for OSA patients.
Magnetic Resonance Imaging (MRI)
Inverse correlation between the ratio of gray matter volume to total brain volume and the visual-fine motor coordination score has been demonstrated using 3D-MRI images of the brain in children. 32 
Functional MRI (FMRI)
Reduction in brain activation in cingulate, frontal, and parietal regions was found in OSA patients. 38 Similarly, decreased activation in the prefrontal cortex was found to be associated with impaired executive function. 39 
Magnetic Resonance Spectroscopy (MRS)
An old study found frontal white matter metabolic abnormalities in OSA patients. 40 However, lately, focal reductions in frontal gyrus, hippocampus, and parietal cortex have shown correlation with cognitive impairments. 41 The emerging evidence that gray matter density changes may precede an objective neurocognitive decline in OSA that has trigged a search for markers which can be used in future for screening. 42 In addition, the response of these changes after CPAP therapy gives rise to the concept of neuroplasticity and the partially reversible features of this neurocognitive dysfunction. 41 treAtment CPAP prevents airway collapse, improves respiratory pattern, prevents hypoxia, and corrects sleep fragmentation in OSA. This, in turn, improves daytime sleepiness and neurocognitive dysfunction. The literature supports the response of CPAP for all severities of OSA across all time periods of use in improving excessive daytime sleepiness. 43 A meta-analysis reported improvement in objective daytime wakefulness [maintenance of wakefulness test (MWT)] with CPAP but no change in objective daytime sleepiness [multiple sleep latency test (MSLT)] in mild OSA. 43 Several studies have shown that CPAP corrects nocturnal hypoxemia, sleep quality, sleepiness and cognition; the effects being more subjective and higher in severe OSA. 44 -47 CPAP has shown to partly reversed neurocognitive deficits after 3-6 months of use in OSA with excessive daytime sleepiness. The improvement was in attention, vigilance, verbal and visual memory, delayed long-term executive dysfunction, and global cognitive function, but, these were small sample size studies. 48 -50 A recent large multicenter trial also reported a transient improvement in frontal-lobe and executive function in severe OSA patients after CPAP. 51 However, not all the cognitive functions improve with CPAP. A study concluded that while most executive functions improve, short-term memory impairment persists. 52 Another study demonstrated no dose-response effect of CPAP in the improvement of verbal memory loss. 53 It has been suggested that this may be due to irreversible chronic hypoxic cerebral damage, particularly in frontal lobes. Besides, the cognitive decline may also be multifactorial and, hence, not reversible. 53 There are very few studies to study the role of CPAP in OSA without daytime sleepiness evaluating the effect of CPAP on OSA patients without EDS. A randomized controlled trial reported no benefit in cognitive function (vigilance, memory, attention, information processing) in OSA with the use of CPAP. 54 conclusIon OSA is a common cause of neurocognitive dysfunction which can be best prevented by early diagnosis and institution of therapy in the form of PAP devices. CPAP has even shown to be partly reverse this neurocognitive decline. Hence, a high index of suspicion should be kept for diagnosing neurocognitive dysfunction in all patients of OSA.
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